Predicting Chemotherapy Benefit across Different Races in Early-Stage Breast Cancer Patients Using the Oncotype DX Score

SIMPLE SUMMARY: The Oncotype DX recurrence score is widely used to help clinicians treat patients with early-stage breast cancer. However, the threshold at which the Oncotype DX score is used to guide chemotherapy treatment may vary for different patient groups, and the present study describes a mac...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaw, Vikram R., Amos, Christopher I., Cheng, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296905/
https://www.ncbi.nlm.nih.gov/pubmed/37370827
http://dx.doi.org/10.3390/cancers15123217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296905/
https://www.ncbi.nlm.nih.gov/pubmed/37370827
http://dx.doi.org/10.3390/cancers15123217

Ejemplares similares